Literature DB >> 8529685

Variability of clinical and immunological phenotype in immunodeficiency-centromeric instability-facial anomalies syndrome. Report of two new patients and review of the literature.

P Franceschini1, S Martino, M Ciocchini, E Ciuti, M P Vardeu, A Guala, F Signorile, P Camerano, D Franceschini, P A Tovo.   

Abstract

Immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome is a condition characterized by variable combined immunodeficiency, developmental delay, facial anomalies and a variety of structural chromosomal rearrangements. Recently, aberrations at the molecular level have been described consisting of alterations in the methylation pattern of classical satellite DNA. To our knowledge 15 subjects have been described so far in the literature showing marked phenotypic variability. We report on two new patients with normal development and some peculiar clinical and immunological manifestations. All patients previously reported in the literature are reviewed. CONCLUSION. The identification of these two cases among our hypogammaglobulinaemic patients suggests that ICF syndrome is not a rare disorder and it should be always taken into account in immunodeficient patients with facial abnormalities.

Entities:  

Mesh:

Year:  1995        PMID: 8529685     DOI: 10.1007/bf01959794

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  17 in total

1.  Interphase cytogenetics of the ICF syndrome.

Authors:  P Maraschio; M Cortinovis; E Dainotti; R Tupler; L Tiepolo
Journal:  Ann Hum Genet       Date:  1992-07       Impact factor: 1.670

2.  Fragility of the centromeric region of chromosome 1 associated with combined immunodeficiency in siblings. A recessively inherited entity?

Authors:  A Fasth; E Forestier; E Holmberg; G Holmgren; I Nordenson; T Söderström; J Wahlström
Journal:  Acta Paediatr Scand       Date:  1990 Jun-Jul

3.  Variable immunodeficiency with abnormal condensation of the heterochromatin of chromosomes 1, 9, and 16.

Authors:  N J Carpenter; A Filipovich; R M Blaese; T L Carey; A I Berkel
Journal:  J Pediatr       Date:  1988-05       Impact factor: 4.406

Review 4.  Centromeric heterochromatin instability of chromosomes 1, 9, and 16 in variable immunodeficiency syndrome--a virus-induced phenomenon?

Authors:  O A Haas
Journal:  Hum Genet       Date:  1990-07       Impact factor: 4.132

Review 5.  A new chromosomal instability disorder confirmed by complementation studies.

Authors:  R D Wegner; M Metzger; F Hanefeld; N G Jaspers; C Baan; K Magdorf; J Kunze; K Sperling
Journal:  Clin Genet       Date:  1988-01       Impact factor: 4.438

6.  Centromeric instability of chromosomes 1, 9 and 16 with variable immune deficiency. Support of a new syndrome.

Authors:  G Valkova; E Ghenev; M Tzancheva
Journal:  Clin Genet       Date:  1987-03       Impact factor: 4.438

7.  Centromeric instability of chromosomes 1, 9, and 16 associated with combined immunodeficiency.

Authors:  J P Fryns; M Azou; J Jaeken; E Eggermont; J C Pedersen; H Van den Berghe
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

Review 8.  [ICF syndrome. Immunodeficiency, chromosomal centromere instability, facial anomalies. Case report and literature review].

Authors:  P Kieback; H Wendisch; P Lorenz; K Hinkel
Journal:  Monatsschr Kinderheilkd       Date:  1992-02       Impact factor: 0.323

9.  An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome.

Authors:  M Jeanpierre; C Turleau; A Aurias; M Prieur; F Ledeist; A Fischer; E Viegas-Pequignot
Journal:  Hum Mol Genet       Date:  1993-06       Impact factor: 6.150

Review 10.  ICF syndrome: a new case and review of the literature.

Authors:  D F Smeets; U Moog; C M Weemaes; G Vaes-Peeters; G F Merkx; J P Niehof; G Hamers
Journal:  Hum Genet       Date:  1994-09       Impact factor: 4.132

View more
  6 in total

1.  EBV-Related Hodgkin Lymphoma in an ICF2 Patient: Is EBV Susceptibility a Hallmark of This ICF Subtype?

Authors:  Francesco Licciardi; Marlinde van den Boogaard; Marta Delle Piane; Pier Angelo Tovo; Davide Montin
Journal:  J Clin Immunol       Date:  2019-02-04       Impact factor: 8.317

2.  Genetic, Cellular and Clinical Features of ICF Syndrome: a French National Survey.

Authors:  Delphine Sterlin; Guillaume Velasco; Despina Moshous; Fabien Touzot; Nizar Mahlaoui; Alain Fischer; Felipe Suarez; Claire Francastel; Capucine Picard
Journal:  J Clin Immunol       Date:  2016-02-06       Impact factor: 8.317

Review 3.  Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF).

Authors:  Melanie Ehrlich; Kelly Jackson; Corry Weemaes
Journal:  Orphanet J Rare Dis       Date:  2006-03-01       Impact factor: 4.123

4.  Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling.

Authors:  Katarina Lopusna; Pawel Nowialis; Jana Opavska; Ajay Abraham; Alberto Riva; Rene Opavsky
Journal:  EBioMedicine       Date:  2021-01-05       Impact factor: 8.143

Review 5.  Approach to the patient with recurrent infections.

Authors:  Mark Ballow
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 10.817

Review 6.  ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation.

Authors:  Melanie Ehrlich; Cecilia Sanchez; Chunbo Shao; Rie Nishiyama; John Kehrl; Rork Kuick; Takeo Kubota; Samir M Hanash
Journal:  Autoimmunity       Date:  2008-05       Impact factor: 2.815

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.